𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1409 THE NEW DUAL PPARα/δ AGONIST GFT505 IMPROVES HEPATIC INSULIN RESISTANCE AND DECREASES SERUM LIVER ENZYMES IN ABDOMINALLY OBESE PATIENTS

✍ Scribed by Cariou, B.; Hanf, R.; Lambert-Porcheron, S.; Zaïr, Y.; Flet, L.; Staels, B.; Laville, M.


Book ID
123124284
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
80 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.